We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHT icon
4851
Chunghwa Telecom
CHT
$33B
$2.71M ﹤0.01%
65,578
+24,276
+59% +$1.05M
TAIL icon
4852
Cambria Tail Risk ETF
TAIL
$146M
$2.7M ﹤0.01%
+153,798
New +$2.61M
VICR icon
4853
Vicor
VICR
$10.8B
$2.7M ﹤0.01%
49,370
-12,574
-20% -$780K
SILV
4854
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$2.7M ﹤0.01%
442,073
-234,978
-35% -$1.78M
MBUU icon
4855
Malibu Boats
MBUU
$576M
$2.7M ﹤0.01%
51,221
+34,711
+210% +$1.88M
ABB
4856
PUT
DELISTED
ABB Ltd
ABB
$2.7M ﹤0.01%
100,900
-269,900
-73% -$8.02M
CRHC
4857
PUT
DELISTED
Cohn Robbins Holdings Corp.
CRHC
$2.7M ﹤0.01%
271,300
-47,200
-15% -$469K
COO icon
4858
CALL
Cooper Companies
COO
$14.9B
$2.69M ﹤0.01%
34,400
-29,200
-46% -$2.58M
AVES icon
4859
Avantis Emerging Markets Value ETF
AVES
$1.49B
$2.69M ﹤0.01%
63,671
+47,863
+303% +$2.19M
VUZI icon
4860
CALL
Vuzix
VUZI
$262M
$2.69M ﹤0.01%
379,100
+127,400
+51% +$748K
SFIX
4861
CALL
Stitch Fix
SFIX
$479M
$2.69M ﹤0.01%
544,500
+30,200
+6% +$253K
PAM icon
4862
Pampa Energía
PAM
$4.23B
$2.69M ﹤0.01%
131,298
+43,707
+50% +$968K
SUPN icon
4863
Supernus Pharmaceuticals
SUPN
$2.81B
$2.69M ﹤0.01%
92,920
-13,341
-13% -$382K
BPOP icon
4864
PUT
Popular Inc
BPOP
$11.3B
$2.69M ﹤0.01%
34,900
+17,300
+98% +$1.38M
MRVI icon
4865
CALL
Maravai LifeSciences
MRVI
$849M
$2.69M ﹤0.01%
94,500
-18,900
-17% -$599K
USAC icon
4866
CALL
USA Compression Partners
USAC
$3.86B
$2.69M ﹤0.01%
160,600
+38,600
+32% +$693K
OMF icon
4867
PUT
OneMain Financial
OMF
$7.56B
$2.68M ﹤0.01%
71,800
+4,600
+7% +$199K
CYRX icon
4868
CALL
CryoPort
CYRX
$772M
$2.68M ﹤0.01%
86,600
-86,400
-50% -$2.3M
SLG icon
4869
CALL
SL Green Realty
SLG
$3.97B
$2.68M ﹤0.01%
58,145
-12,287
-17% -$781K
BIOX icon
4870
CALL
Bioceres Crop Solutions
BIOX
$28.7M
$2.68M ﹤0.01%
195,600
+98,500
+101% +$1.31M
TNDM icon
4871
Tandem Diabetes Care
TNDM
$1.58B
$2.68M ﹤0.01%
45,300
-468,688
-91% -$38.5M
VOE icon
4872
CALL
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
$2.68M ﹤0.01%
20,700
-500
-2% -$70.7K
FIX icon
4873
Comfort Systems
FIX
$62.4B
$2.68M ﹤0.01%
32,231
+5,980
+23% +$514K
ARKQ icon
4874
PUT
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.1B
$2.68M ﹤0.01%
53,500
-29,300
-35% -$1.64M
AGO icon
4875
CALL
Assured Guaranty
AGO
$3.38B
$2.68M ﹤0.01%
48,000
-39,900
-45% -$2.3M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.